Latest ANGN reports update at 2024-03-29: 20232022
Angion Biomedica Corp. logo
Angion Biomedica Corp. ANGN
$ 1.0 2.04%

Angion Biomedica Corp. Financial Statements 2011-2024 | ANGN

Annual Financial Statements Angion Biomedica Corp.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

5.06 M 161 K 76.3 M - - - - - - - - - -

Shares

5.06 M 316 K 28.2 M - - - - - - - - - -

Historical Prices

1 0.51 2.7 - - - - - - - - - -

Net Income

-35.2 M -28.2 M -54.6 M -80.1 M - - - - - - - - -

Revenue

- - 28.3 M 2.88 M - - - - - - - - -

Cost of Revenue

- - 433 K 1.19 M - - - - - - - - -

Gross Profit

- - - 1.69 M - - - - - - - - -

Operating Income

-35.7 M -23.7 M -39.3 M -55.3 M - - - - - - - - -

Interest Expense

1.06 M 3.6 M -1.85 M -8.85 M - - - - - - - - -

EBITDA

-35.4 M -23.3 M -39.2 M -55.3 M - - - - - - - - -

Operating Expenses

- - - 57 M - - - - - - - - -

General and Administrative Expenses

11.9 M 5.63 M 18.5 M 18 M - - - - - - - - -

All numbers in USD currency

Quarterly Income Statement Angion Biomedica Corp.

2023-Q3 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

8.38 M 30.1 M 320 K 318 K 30 M 30 M 30 M 29.8 M 29.7 M 23.4 M 15.3 M 14.8 M 14.5 M 14.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-10.7 M -4.54 M - -7.2 M -9.14 M -14.2 M - -15.7 M -17.1 M -36.7 M - -17.7 M -20.3 M -13.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - 653 K 1.65 M - 1.46 M 540 K 371 K - 827 K 729 K 865 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - 348 K 333 K 383 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-10.8 M -4.61 M - -5.77 M -9.04 M -14.5 M - -15.8 M -18.2 M -19.9 M - -11.6 M -17.3 M -12.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

1 K 469 K - 1.08 M 58 K 86 K - 110 K 124 K -2.17 M - -2.58 M -487 K -180 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -4.58 M - -5.67 M -8.97 M -14.5 M - -15.7 M -18.2 M -19.9 M - -11.5 M -17.2 M -12.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

3.51 M 4.28 M - 1.18 M 3.62 M 4.47 M - 3.93 M 4.34 M 6.01 M - 5.98 M 5.44 M 3.46 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency